The product of this gene is a membrane protein expressed on the oligodendrocyte cell surface and the outermost surface of myelin sheaths. Due to this localization, it is a primary target antigen involved in immune-mediated demyelination. This protein may be involved in completion and maintenance of the myelin sheath and in cell-cell communication. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008].
Buerth, Mausberg, Heininger, Hartung, Kieseier, Ernst: "Oral Tolerance Induction in Experimental Autoimmune Encephalomyelitis with Candida utilis Expressing the Immunogenic MOG35-55 Peptide." in: PLoS ONE, Vol. 11, Issue 5, pp. e0155082, (2016) (PubMed).
Francosalinas, Cantaert, Nolte, Tak, van Lier, Baeten: "Enhanced costimulation by CD70+ B cells aggravates experimental autoimmune encephalomyelitis in autoimmune mice." in: Journal of neuroimmunology, Vol. 255, Issue 1-2, pp. 8-17, (2013) (PubMed).
Adamus, Brown, Andrew, Meza-Romero, Burrows, Vandenbark: "Neuroprotective effects of recombinant T-cell receptor ligand in autoimmune optic neuritis in HLA-DR2 mice." in: Investigative ophthalmology & visual science, Vol. 53, Issue 1, pp. 406-12, (2012) (PubMed).
Zai, King, Wigg, Couto, Wong, Honer, Barr, Kennedy: "Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia." in: Genes, brain, and behavior, Vol. 4, Issue 1, pp. 2-9, (2005) (PubMed).